|
|
Volumn 141, Issue 1, 2015, Pages 185-187
|
|
Response to crizotinib observed in metastatic mediastinum lymph node from a non-small cell lung cancer patient harboring EZR–ROS1 fusion
a,b
a,b
a,b
a,b
a,b
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
CRIZOTINIB;
EZRIN;
GEMCITABINE;
HYBRID PROTEIN;
PEMETREXED;
ROS1 PROTEIN;
UNCLASSIFIED DRUG;
CYTOSKELETON PROTEIN;
ONCOPROTEIN;
PROTEIN KINASE INHIBITOR;
PROTEIN TYROSINE KINASE;
PYRAZOLE DERIVATIVE;
PYRIDINE DERIVATIVE;
ROS1 PROTEIN, HUMAN;
AGED;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER CONTROL;
CANCER PATIENT;
CANCER SIZE;
CANCER STAGING;
CASE REPORT;
CHEMOTHERAPY INDUCED EMESIS;
COMPUTER ASSISTED TOMOGRAPHY;
DRUG EFFICACY;
DRUG SAFETY;
DRUG WITHDRAWAL;
FATIGUE;
FEMALE;
FLUORESCENCE IN SITU HYBRIDIZATION;
FUSION GENE;
GASTROINTESTINAL SYMPTOM;
HISTOPATHOLOGY;
HUMAN;
LETTER;
LUNG ADENOCARCINOMA;
LUNG BIOPSY;
LUNG LOBE;
LUNG LOBECTOMY;
LUNG NODULE;
LYMPH NODE DISSECTION;
LYMPH NODE METASTASIS;
MEDIASTINUM LYMPH NODE;
MEDIASTINUM LYMPH NODE METASTASIS;
MEDIASTINUM LYMPHADENOPATHY;
MEDIASTINUM METASTASIS;
MULTIPLE CYCLE TREATMENT;
NAUSEA;
NON SMALL CELL LUNG CANCER;
PLEURA;
PLEURA METASTASIS;
PRIORITY JOURNAL;
RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
SUPERIOR CAVA VEIN;
THORACOTOMY;
TISSUE SECTION;
TREATMENT RESPONSE;
CARCINOMA, NON-SMALL-CELL LUNG;
GENETICS;
LUNG NEOPLASMS;
MEDIASTINAL NEOPLASMS;
PATHOLOGY;
PROGNOSIS;
SECONDARY;
AGED;
CARCINOMA, NON-SMALL-CELL LUNG;
CYTOSKELETAL PROTEINS;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
LYMPHATIC METASTASIS;
MEDIASTINAL NEOPLASMS;
ONCOGENE PROTEINS, FUSION;
PROGNOSIS;
PROTEIN KINASE INHIBITORS;
PROTEIN-TYROSINE KINASES;
PROTO-ONCOGENE PROTEINS;
PYRAZOLES;
PYRIDINES;
TOMOGRAPHY, X-RAY COMPUTED;
|
|
EID: 84925031724
PISSN: 01715216
EISSN: 14321335
Source Type: Journal
DOI: 10.1007/s00432-014-1821-1 Document Type: Letter |
|
Times cited : (7)
|
|
References (5)
|
